141 related articles for article (PubMed ID: 1980130)
1. Dynorphin A-(1-17) induces alterations in free fatty acids, excitatory amino acids, and motor function through an opiate-receptor-mediated mechanism.
Bakshi R; Newman AH; Faden AI
J Neurosci; 1990 Dec; 10(12):3793-800. PubMed ID: 1980130
[TBL] [Abstract][Full Text] [Related]
2. Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury.
Faden AI
Ann Neurol; 1990 Jan; 27(1):67-74. PubMed ID: 1967925
[TBL] [Abstract][Full Text] [Related]
3. N-methyl-D-aspartate (NMDA) and opioid receptors mediate dynorphin-induced spinal cord injury: behavioral and histological studies.
Bakshi R; Ni RX; Faden AI
Brain Res; 1992 May; 580(1-2):255-64. PubMed ID: 1380394
[TBL] [Abstract][Full Text] [Related]
4. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action.
Faden AI; Jacobs TP
Br J Pharmacol; 1984 Feb; 81(2):271-6. PubMed ID: 6142741
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal administration of dynorphin A and its fragments increase heart rate and arterial pressure in the urethane anesthetized rat: mediation by a nonopioid mechanism.
Rochford J; Godin C; Henry JL
Brain Res; 1991 Nov; 565(1):67-77. PubMed ID: 1685349
[TBL] [Abstract][Full Text] [Related]
6. Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the kappa opioid antagonist nor-binaltorphimine.
Long JB; Rigamonti DD; de Costa B; Rice KC; Martinez-Arizala A
Brain Res; 1989 Sep; 497(1):155-62. PubMed ID: 2571391
[TBL] [Abstract][Full Text] [Related]
7. Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity.
Stevens CW; Yaksh TL
J Pharmacol Exp Ther; 1986 Sep; 238(3):833-8. PubMed ID: 2875172
[TBL] [Abstract][Full Text] [Related]
8. [Receptor mechanism of dynorphin A in rat secondary spinal cord injuries].
Li M; Yang Y; Hong X
Zhonghua Yi Xue Za Zhi; 1996 Apr; 76(4):290-3. PubMed ID: 8758278
[TBL] [Abstract][Full Text] [Related]
9. Endogenous opioids in spinal cord injury: a critical evaluation.
Long JB; Martinez-Arizala A; Petras JM; Holaday JW
Cent Nerv Syst Trauma; 1986; 3(4):295-315. PubMed ID: 2884046
[TBL] [Abstract][Full Text] [Related]
10. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses.
Long JB; Mobley WC; Holaday JW
J Pharmacol Exp Ther; 1988 Sep; 246(3):1158-66. PubMed ID: 2901486
[TBL] [Abstract][Full Text] [Related]
11. Involvement of spinal kappa opioid receptors in the antagonistic effect of dynorphins on morphine antinociception.
Song ZH; Takemori AE
Life Sci; 1991; 48(15):1447-53. PubMed ID: 1672725
[TBL] [Abstract][Full Text] [Related]
12. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic function.
Long JB; Petras JM; Mobley WC; Holaday JW
J Pharmacol Exp Ther; 1988 Sep; 246(3):1167-74. PubMed ID: 2901487
[TBL] [Abstract][Full Text] [Related]
13. Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism.
Faden AI
J Neurosci; 1992 Feb; 12(2):425-9. PubMed ID: 1346803
[TBL] [Abstract][Full Text] [Related]
14. Increased dynorphin immunoreactivity in spinal cord after traumatic injury.
Faden AI; Molineaux CJ; Rosenberger JG; Jacobs TP; Cox BM
Regul Pept; 1985 May; 11(1):35-41. PubMed ID: 2861626
[TBL] [Abstract][Full Text] [Related]
15. Spinal kappa-opiate receptor involvement in the analgesia of pregnancy: effects of intrathecal nor-binaltorphimine, a kappa-selective antagonist.
Sander HW; Portoghese PS; Gintzler AR
Brain Res; 1988 Dec; 474(2):343-7. PubMed ID: 2850091
[TBL] [Abstract][Full Text] [Related]
16. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
[TBL] [Abstract][Full Text] [Related]
17. Opiate-receptor antagonist nalmefene improves neurological recovery after traumatic spinal cord injury in rats through a central mechanism.
Faden AI; Sacksen I; Noble LJ
J Pharmacol Exp Ther; 1988 May; 245(2):742-8. PubMed ID: 3367315
[TBL] [Abstract][Full Text] [Related]
18. Dynorphins other than dynorphin A(1-17) lack spinal antianalgesic activity but do act on dynorphin A(1-17) receptors.
Rady JJ; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 1991 Dec; 259(3):1073-80. PubMed ID: 1684812
[TBL] [Abstract][Full Text] [Related]
19. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
20. Selective potentiation of NMDA-induced activity and release of excitatory amino acids by dynorphin: possible roles in paralysis and neurotoxicity.
Skilling SR; Sun X; Kurtz HJ; Larson AA
Brain Res; 1992 Mar; 575(2):272-8. PubMed ID: 1349253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
